For U.S. Residents Only

Tissue Penetration

KETEK® penetrates epithelial lining fluid with levels that exceed MICs of common pathogens in CAP-
S pneumoniae and H influenzae*.


tissue penetration

Telithromycin concentrations in epithelial lining fluid evaluated after 800-mg once-daily dosing for 5 days in healthy patient population. 5


*Tissue Penetration does not imply clinical effectiveness. The clinical significance of in vitro activity is unknown